Global Acute Myeloid Leukemia Drug Pipeline Capsule - 2012

Fore Pharma, January 2012, Pages: 15

Fore Pharma’s latest report ‘Global Acute Myeloid Leukemia Drug Pipeline Capsule – 2012’ is an outline of all the key research and development (R&D) activities of the global Acute Myeloid Leukemia drug market. It covers information on key pipeline molecules in various stages of R&D including all the phases of clinical trials, preclinical research, and drug discovery. The report is up-to-date with full coverage of the licensing activities and partnerships.

This report helps executives to keep a track of their competitors and understand their pipeline molecules. The information presented in this report can be used for identifying the partners, prioritizing, evaluating opportunities, developing business development strategies, and executing in-licensing and out-licensing deals.

The report provides information on pipeline molecules by company and mechanism of action across the different stages of R&D. It includes registered / preregistered stage, phase 3 clinical trial, phase 2 clinical trial, phase 1 clinical trial, preclinical research, and drug discovery. It also provides information on pipeline molecules developed in leading geographies including the U.S., Canada, France, Germany, U.K., Italy, and Spain by various stages of R&D. Licensing activities and partnerships in the Acute Myeloid Leukemia drug market is thoroughly covered by company and licensee with the deal summary.

Key Features of the Report:
- Acute Myeloid Leukemia: Overview
- Acute Myeloid Leukemia Drug Pipeline Overview
- Acute Myeloid Leukemia Phase 3 Clinical Trial Drug Pipeline Insights
- Acute Myeloid Leukemia Phase 2 Clinical Trial Drug Pipeline Insights
- Acute Myeloid Leukemia Phase 1 Clinical Trial Drug Pipeline Insights
- Acute Myeloid Leukemia Preclinical Research Drug Pipeline Insights
- Acute Myeloid Leukemia Drug Discovery Pipeline Insights
- Geographic Landscape of Acute Myeloid Leukemia R&D Activities
- Acute Myeloid Leukemia R&D Activities in North America
- Acute Myeloid Leukemia R&D Activities in Europe
- Licensing Activities / Partnerships in the Global Acute Myeloid Leukemia Drug Market

1. Acute Myeloid Leukemia: Disease Definition
2. Acute Myeloid Leukemia Drug Pipeline Overview
3. Acute Myeloid Leukemia Phase 3 Clinical Trial Drug Pipeline Insights
4. Acute Myeloid Leukemia Phase 2 Clinical Trial Drug Pipeline Insights
5. Acute Myeloid Leukemia Phase 1 Clinical Trial Drug Pipeline Insights
6. Acute Myeloid Leukemia Preclinical Research Drug Pipeline Insights
7. Acute Myeloid Leukemia Drug Discovery Pipeline Insights
8. Geographic Landscape of Acute Myeloid Leukemia R&D Activities
8.1. Acute Myeloid Leukemia R&D Activities in North America
8.2. Acute Myeloid Leukemia R&D Activities in Europe
9. Licensing Activities / Partnerships in the Global Acute Myeloid Leukemia Drug Market
10. Research Methodology
Table 1: Acute Myeloid Leukemia Drug Pipeline: Phase 3 Clinical Trial Molecules
Table 2: Acute Myeloid Leukemia Drug Pipeline: Phase 2 Clinical Trial Molecules
Table 3: Acute Myeloid Leukemia Drug Pipeline: Phase 1 Clinical Trial Molecules
Table 4: Acute Myeloid Leukemia Drug Pipeline: Preclinical Research Molecules
Table 5: Acute Myeloid Leukemia R&D Activities by Geography
Table 6: Acute Myeloid Leukemia Drug Pipeline: North America
Table 7: Acute Myeloid Leukemia Drug Pipeline: Europe
Table 8: Acute Myeloid Leukemia Drug Pipeline: Licensing Activities
Figure 1 : Acute Myeloid Leukemia Drug Pipeline Molecules by Stages
Figure 2 : Acute Myeloid Leukemia R&D Activities by Geography

Customers who bought this item also bought

• Global Acute Myeloid Leukemia Pipeline Capsule - 2013
• Global Acute Myeloid Leukemia Epidemiology and Patient Flow Analysis - 2012
• Global Chronic Myeloid Leukemia Pipeline Capsule - 2013
• Global Hematologic Disorders Drug Pipeline Capsule – 2012
• Global Chronic Myeloid Leukemia Drug Pipeline Capsule - 2011
• Global Chronic Myeloid Leukemia Drug Pipeline Capsule - 2012 Update
• Leukemia Therapeutics Market (2010-2020) (Acute/Chronic lymphocytic leukemia & Acute/Chronic myeloid leukemia) Pipeline forecast & Market forecast in G8 countries
• Global Acute Myeloid Leukaemia Drug Pipeline Capsule - 2012 Update
• Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) - Pipeline Review, H1 2013
• Global Leukemia Pipeline Capsule - 2013